Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

The Catastrophically Delayed COVID Shot Heart Disease Signal - Failure or Crypto-Eugenics In Israel and the US. (opens in a new tab)

Failure or Crypto-Eugenics In Israel and the US. · 2026-09-12

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1

The story

The Catastrophically Delayed COVID Shot Heart Disease Signal - Failure or Crypto-Eugenics In Israel and the US.

Failure or Crypto-Eugenics In Israel and the US. · 2026-09-12

The story’s checkable claims.

Read the original story (opens in a new tab)
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Source paper

Source layer

The 8 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 22 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 9Not checkedIsrael and Pfizer had a real-world data-sharing relationship beginning in January 2021, and Israel was sending effectiveness and safety data to Pfizer while myocarditis reports were also moving through pharmacovigilance channels.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 9Not checkedOn February 28, 2021, Israel’s Ministry of Health contacted the CDC and EMA about “a large number of reports of myocarditis, particularly in young people,” after Pfizer vaccination.View evidenceHide evidence

As stateda large number of reports

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 9Not checkedThe article says Israel’s internal file had already recorded 157 hospitalizations and 46 deaths by March 25, 2021, including 65 myocarditis or pericarditis hospitalizations, and later grew to 531 hospitalization records and 67 unique deaths.View evidenceHide evidence

As stated157 hospitalizations and 46 deaths; later 531 hospitalization records and 67 unique deaths

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 9Not checkedIsrael presented its safety data to the CDC/FDA VaST work group on April 5, 2021, and the article says those slides documented 62 myocarditis cases, 15 pericarditis cases, and 48 deaths reported in proximity to vaccination.View evidenceHide evidence

As stated62 myocarditis cases, 15 pericarditis cases, 48 deaths

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 9Not checkedThe article argues that Israel’s domestic vaccine-side-effect reporting system failed badly: most reports were not entered, some health funds had missing or rejected submissions, and the Ministry kept an Excel-based tracking file with no audit trail.View evidenceHide evidence

As stated82% missing; 354,200 reports received, 62,000 recorded

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 6 of 9Not checkedFor the United States, the article claims Israel’s myocarditis warning reached CDC/FDA in late February and early March 2021, but U.S. officials initially minimized the signal and said they had no evidence of a problem from VAERS/VSD.View evidenceHide evidence

As statednearly four months

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 7 of 9Not checkedThe article says CDC and FDA chose not to issue a Health Alert Network bulletin, softened the messaging into a webpage, and the public-facing acknowledgment of myocarditis came later and in weaker form than the draft warning.View evidenceHide evidence

As statednearly four months

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 8 of 9Not checkedThe article presents ACIP and later studies as showing that myocarditis risk was concentrated in young males and that some myocarditis cases had persistent MRI findings, while also stating that vaccinated myocarditis outcomes were generally better than infection-associated myocarditis.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 9 of 9Not checkedThe article argues that officials used benefit-risk framing that treated vaccination and infection as mutually exclusive, despite vaccines not reliably preventing infection, and that this understating of risk was a communications choice rather than a technical constraint.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

Crossref, PubMed, Europe PMC · 22 candidate papers

And 17 more candidates considered.